financetom
Business
financetom
/
Business
/
Sonder Secures New Funding, Amends Marriott Agreement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sonder Secures New Funding, Amends Marriott Agreement
Aug 8, 2025 4:47 AM

Sonder Holdings Inc. ( SOND ) shares surged on Friday following the company's announcement of a new financing plan aimed at reinforcing its liquidity and supporting future growth.

On August 5, 2025, the company raised $24.54 million through the issuance of units consisting of senior secured promissory notes and warrants to buy common stock at an exercise price of $1.50 per share.

The notes carry a 15% annual interest rate and mature in July 2026. To finalize aspects of the transaction, Sonder ( SOND ) will seek shareholder approval on matters related to the warrant issuance.

Also Read: Airbnb Impresses With Earnings, Yet Wall Street Flags Travel Headwinds And Tougher Comps

Sonder ( SOND ) has also secured backing from shareholders holding a majority of voting power to ensure passage of related proposals. In tandem, the company amended its agreement with Marriott International Inc. ( MAR ) , converting up to one year's worth of fees into obligations under senior secured notes.

Additionally, Sonder ( SOND ) ended its existing Loan and Security Agreement with Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, while maintaining access to letters of credit, a move that improves financial agility without expanding debt exposure.

“The additional liquidity is intended to help Sonder ( SOND ) execute our strategic plan and position the Company for long-term growth and value creation,” said Janice Sears, Interim CEO.

Sonder's ( SOND ) recent earnings highlight ongoing efforts to improve performance and scale operations. To review financial updates from its most recent reporting period, see the full financial results.

Investors may also consider Global X Travel & Leisure ETF and Defiance Hotel, Airline, and Cruise ETF .

Price Action: SOND shares rose by 8.17% to $2.25 in after-hours trading on Thursday.

Read Next:

Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oil Price Slide Spoils Equinor's Strongest Production Year Ever
Oil Price Slide Spoils Equinor's Strongest Production Year Ever
Mar 11, 2026
Equinor ASA ( EQNR ) stock fell Wednesday after the company reported fourth-quarter fiscal 2025 results. Adjusted revenue declined 4% year over year (Y/Y) to $25.26 billion, beating the consensus of $20.17 billion. Earnings Details Equinor ( EQNR ) reported an adjusted operating income of $6.20 billion in the quarter, down 22% Y/Y due to lower liquids prices. The company posted adjusted operating income of $5.03 billion from E&P...
Novo Nordisk sees 'painful' US price cuts for Wegovy as investment in  the future
Novo Nordisk sees 'painful' US price cuts for Wegovy as investment in  the future
Mar 11, 2026
COPENHAGEN, Feb 4 (Reuters) - Novo Nordisk CEO Mike Doustdar said on Wednesday that ‌the price reductions for ​its obesity drug Wegovy ‍in the U.S. ⁠are painful ⁠for the company's financial results ‌but he ​hopes that they will be an ⁠investment in ‍the ​future as many more people will be able ‍to get access to the medicines as a result....
SiTime in Talks With Renesas Over Potential Acquisition of Timing Business
SiTime in Talks With Renesas Over Potential Acquisition of Timing Business
Mar 11, 2026
05:53 AM EST, 02/04/2026 (MT Newswires) -- SiTime ( SITM ) said Tuesday it is in discussions with Renesas Electronics about a possible acquisition of Renesas' timing business. The company said no agreement has been reached and there is no assurance that the talks will lead to a transaction or on what terms. SiTime ( SITM ) said it does...
GSK expects softer 2026 sales growth as new CEO Miels prepares change in course
GSK expects softer 2026 sales growth as new CEO Miels prepares change in course
Mar 11, 2026
* GSK says vaccine and general medicines sales may decline in 2026 * Company maintains long-term targets * GSK shifting focus to pipeline expansion and commercial execution * Q4 and 2025 sales beat analyst expectations (Adds details, background, analyst consensus and shares) Feb 4 (Reuters) - In the first outlook presented by new CEO Luke Miels, ‌GSK on Wednesday said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved